Chinese pharmaceutical group Jiangsu Hengrui Pharmaceuticals (SHE: 600276) is set to raise up to HK$9.89 billion ($1.27 ...

Danish diabetes and weight loss juggernaut Novo Nordisk is to part ways with its chief executive Lars Fruergaard Jørgensen as ...

Telomir Pharmaceuticals (Nasdaq: TLO), a US age-reversal science-based biotech, has identified Telomir-Ag2 as a novel drug ...

US biopharma Biohaven has been told by the US Food and Drug Administration (FDA) that the agency is extending the PDUFA date ...

Neurocrine Biosciences, the American biotech, has unveiled new data showing its drug Crenessity (crinecerfont) may help ...

California’s BioMarin Pharmaceutical is to acquire Inozyme Pharma for $4 per share in an all-cash transaction for a total consideration of approximately $270 million.

Irish contract research organization ICON (Nasdaq: ICON) has retained its position as the most active CRO worldwide in the ...

Pathos AI, a US biotech specializing in artificial intelligence for cancer drug development, has raised $365 million in a ...

New York-based Pathos AI, a biotech company applying artificial intelligence (AI) to drug development, has announced a $365 ...

US clinical-stage biotech Therini Bio yesterday revealed that it raised $39 million in a Series A extension financing, which ...

The US Food and Drug Administration’s (FDA biosimilar approvals reached a record 19 in 2024, with projections indicating that ...

A federal jury in Delaware put US biotech major Amgen (Nasdaq: AMGN) on the hook Thursday for at least $271.2 million in ...